Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-RPS6 Antibody (R3P16)

Catalog #:   RHF53002 Specific References (50) DATASHEET
Host species: Mouse
Isotype: IgG1
Applications: IF, IP, WB
Accession: P62753
Overview

Catalog No.

RHF53002

Species reactivity

Human, Mouse, Rat, Monkey

Host species

Mouse

Isotype

IgG1

Clonality

Monoclonal

Tested applications

IF: 1:50-1:200, IP: 1:20, WB: 1:500-1:1000

Target

40S ribosomal protein S6, Phosphoprotein NP33, RPS6, Small ribosomal subunit protein eS6

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P62753

Applications

IF, IP, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.5% BSA, 0.05% Sodium Azide and 50% Glycerol.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

R3P16

Data Image
  • Immunofluorescence
    Immunocytochemistry analysis of RPS6 in HeLa using S6 Ribosomal Protein antibody.
  • Immunoprecipitation
    Immunoprecipitation analysis of RPS6 in Hela lysates using S6 Ribosomal Protein antibody.
  • Western blot
    Western blot analysis of S6 Ribosomal Protein in Ramos, Jurkat, C6, 3T3 and Hela lysates using S6 Ribosomal Protein antibody.
  • Western blot
    Western blot analysis of RPS6 in CHO-K1, Raji, Raw264.7 and COS7 lysates using RPS6 antibody
References

Development and application of a targeted phosphoproteomics method for analysing the mTOR pathway dynamics in zebrafish PAC2 cell line., PMID:40466985

Synergistic activity of tafasitamab and metronomic chemotherapy on diffuse large B-cell lymphoma through inhibition of the AKT/mTOR signaling pathway., PMID:40175588

Protocol for the visualization of pRps6-positive cells in larval zebrafish brains using whole-mount immunofluorescence and light-sheet microscopy., PMID:39827458

Immunofluorescence for Detection of TOR Kinase Activity In Situ in Photosynthetic Organisms., PMID:39735298

PARP1 acetylation at K119 is essential in regulating the progression and proliferation of cervical cancer cells., PMID:39400626

Elevated antibody binding to striatal cholinergic interneurons in patients with pediatric acute-onset neuropsychiatric syndrome., PMID:39084540

Quantitative proteomics profiling reveals the inhibition of trastuzumab antitumor efficacy by phosphorylated RPS6 in gastric carcinoma., PMID:37507485

Evaluation of the mTORC activity in the presence of Toxoplasma gondii and azathioprine in human monocyte cell line., PMID:36941573

In silico development and experimental validation of a novel 7-gene signature based on PI3K pathway-related genes in bladder cancer., PMID:35896848

Chip-DSF: A rapid screening strategy for drug protein targets., PMID:35809766

Aniridia-related keratopathy relevant cell signaling pathways in human fetal corneas., PMID:35551459

PI3K/AKT/mTOR signaling pathway activity in IDH-mutant diffuse glioma and clinical implications., PMID:35287169

A phospho-proteomic study of cetuximab resistance in KRAS/NRAS/BRAFV600 wild-type colorectal cancer., PMID:34462871

Knockdown of SASS6 reduces growth of MDA‑MB‑231 triple‑negative breast cancer cells through arrest of the cell cycle at the G2/M phase., PMID:33907854

PCR Array Technology in Biopsy Samples Identifies Up-Regulated mTOR Pathway Genes as Potential Rejection Biomarkers After Kidney Transplantation., PMID:33681239

Isoform- and Phosphorylation-specific Multiplexed Quantitative Pharmacodynamics of Drugs Targeting PI3K and MAPK Signaling in Xenograft Models and Clinical Biopsies., PMID:33536190

Comparison of regulatory networks of E74-like factor 1 and cold-shock domain-containing E1 in breast cancer cell lines using ChIP datasets., PMID:33178343

Non-invasive High Frequency Repetitive Transcranial Magnetic Stimulation (hfrTMS) Robustly Activates Molecular Pathways Implicated in Neuronal Growth and Synaptic Plasticity in Select Populations of Neurons., PMID:32612497

Peptide SMIM30 promotes HCC development by inducing SRC/YES1 membrane anchoring and MAPK pathway activation., PMID:32461121

Affinity-Bead Assisted Mass Spectrometry (Affi-BAMS): A Multiplexed Microarray Platform for Targeted Proteomics., PMID:32188029

TGF-β1 inhibits the autophagy of podocytes by activating mTORC1 in IgA nephropathy., PMID:31600491

Modulating EGFR-MTORC1-autophagy as a potential therapy for persistent fetal vasculature (PFV) disease., PMID:31462148

Rapamycin Prevents Surgery-Induced Immune Dysfunction in Patients with Bladder Cancer., PMID:30563829

Altered Signaling Pathways in Aniridia-Related Keratopathy., PMID:30480741

MiR-129-5p Sensitizes the Response of Her-2 Positive Breast Cancer to Trastuzumab by Reducing Rps6., PMID:29258115

Synaptically driven phosphorylation of ribosomal protein S6 is differentially regulated at active synapses versus dendrites and cell bodies by MAPK and PI3K/mTOR signaling pathways., PMID:28716954

IL-3 up-regulates and activates human eosinophil CD32 and αMβ2 integrin causing degranulation., PMID:28000949

The Arabidopsis TOR Kinase Specifically Regulates the Expression of Nuclear Genes Coding for Plastidic Ribosomal Proteins and the Phosphorylation of the Cytosolic Ribosomal Protein S6., PMID:27877176

Signaling pathways controlling activity-dependent local translation of BDNF and their localization in dendritic arbors., PMID:27270670

Synaptic activation of ribosomal protein S6 phosphorylation occurs locally in activated dendritic domains., PMID:27194793

Phenotypically Dormant and Immature Leukaemia Cells Display Increased Ribosomal Protein S6 Phosphorylation., PMID:26985829

A single 60-min bout of peristaltic pulse external pneumatic compression transiently upregulates phosphorylated ribosomal protein s6., PMID:26769680

Phosphorylated ribosomal S6 (p-rpS6) as a post-treatment indicator of HER2 signalling targeted drug resistance., PMID:26329528

Immunohistochemical Assessment of Phosphorylated mTORC1-Pathway Proteins in Human Brain Tumors., PMID:25993328

Response to dual HER2 blockade in a patient with HER3-mutant metastatic breast cancer., PMID:25953157

TORC1 promotes phosphorylation of ribosomal protein S6 via the AGC kinase Ypk3 in Saccharomyces cerevisiae., PMID:25767889

Protein phosphorylation profiling identifies potential mechanisms for direct immunotoxicity., PMID:25715851

Ductal adenocarcinoma of the pancreas usually retained SMAD4 and p53 protein status as well as expression of epithelial-to-mesenchymal transition markers and cell cycle regulators at the stage of liver metastasis., PMID:25119169

Attenuation of replication stress-induced premature cellular senescence to assess anti-aging modalities., PMID:24984966

Boolean ErbB network reconstructions and perturbation simulations reveal individual drug response in different breast cancer cell lines., PMID:24970389

Mapping pathological phenotypes in a mouse model of CDKL5 disorder., PMID:24838000

Anthrax lethal toxin inhibits translation of hypoxia-inducible factor 1α and causes decreased tolerance to hypoxic stress., PMID:24366872

Sym004, a novel EGFR antibody mixture, can overcome acquired resistance to cetuximab., PMID:24204198

Evaluation of EGFR and RTK signaling in the electrotaxis of lung adenocarcinoma cells under direct-current electric field stimulation., PMID:23951353

Targeting AKT with the allosteric AKT inhibitor MK-2206 in non-small cell lung cancer cells with acquired resistance to cetuximab., PMID:23760490

Regulation of the ERK pathway in the dentate gyrus by in vivo dopamine D1 receptor stimulation requires glutamatergic transmission., PMID:22796106

Relationship between ATM and ribosomal protein S6 revealed by the chemical inhibition of Ser/Thr protein phosphatase type 1., PMID:22451389

Tetraspanins stimulate protein synthesis in myeloma cell lines., PMID:22415769

Strong EGFR signaling in cell line models of ERBB2-amplified breast cancer attenuates response towards ERBB2-targeting drugs., PMID:23552733

A genome-wide RNAi screen for polypeptides that alter rpS6 phosphorylation., PMID:22125066

Datasheet

Document Download

Anti-RPS6 Antibody (R3P16).pdf

 

$ 220
Product specifications
50 μg 220 100 μg 350

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-RPS6 Antibody (R3P16) [RHF53002]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only